OVID
NASDAQ · Biotechnology
Ovid Therapeutics Inc
$2.43
+0.03 (+1.25%)
Open$2.40
Previous Close$2.40
Day High$2.46
Day Low$2.39
52W High$3.11
52W Low$0.27
Volume—
Avg Volume2.32M
Market Cap494.60M
P/E Ratio—
EPS$-0.26
SectorBiotechnology
Analyst Ratings
Strong Buy
17 analysts
Price Target
+1,588.9% upside
Current
$2.43
$2.43
Target
$41.04
$41.04
$30.97
$41.04 avg
$66.83
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 18.03M | 10.66M | 31.11M |
| Net Income | -43,268,015 | -23,029,873 | -8,350,078 |
| Profit Margin | -240.1% | -228.1% | -26.8% |
| EBITDA | -42,590,235 | -23,928,513 | -13,566,183 |
| Free Cash Flow | — | — | -8,976,737 |
| Rev Growth | +69.1% | +69.1% | +19.5% |
| Debt/Equity | — | — | 0.28 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $213.76 | +2.08% | 88.1 | 372.39B |
| AMGN | Amgen Inc | $330.33 | -0.13% | 23.0 | 179.23B |
| GILD | Gilead Sciences Inc | $130.28 | -0.17% | 17.4 | 160.50B |
| VRTX | Vertex Pharmaceuticals Inc | $429.32 | -1.15% | 26.4 | 114.32B |
| REGN | Regeneron Pharmaceuticals | $641.69 | +1.81% | 16.7 | 73.89B |
| ALNY | Alnylam Pharmaceuticals Inc | $293.86 | -0.15% | 66.6 | 38.43B |